1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Comparative study of the mode of action of clinically approved platinum-based chemotherapeutics
(
- Contribution to journal › Article
- 2007
-
Mark
Cell-specific responses to loss of cyclin-dependent kinases
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment.
(
- Contribution to journal › Article
-
Mark
Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.
(
- Contribution to journal › Article
-
Mark
Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
(
- Contribution to journal › Article
-
Mark
The catalytic domain limits the translocation of protein kinase C alpha in response to increases in Ca2+ and diacylglycerol.
(
- Contribution to journal › Article
- 2002
-
Mark
Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype.
(
- Contribution to journal › Article
-
Mark
Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma.
(
- Contribution to journal › Article
-
Mark
Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
(
- Contribution to journal › Article
-
Mark
Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells.
(
- Contribution to journal › Article